1250 GMT May 25, 2019
Proton Partners International has announced it has successfully fired the first high energy proton beam in the UK during testing at The Rutherford Cancer Center in South Wales, express.co.uk wrote.
Treatment at The Rutherford Cancer Centers will be available to medically-insured private patients, self-paying patients and patients referred by the National Health System (NHS).
Proton beam therapy is a type of radiotherapy used in cancer treatment, delivering heavily charged protons in a more targeted manner to reduce damage to unaffected tissue and organs.
The treatment has delivered significant results for patients, especially in lowering side effects — but the treatment is not yet available in the UK.
The NHS refers patients abroad for treatment, and hundreds of others have sought the treatment abroad — flying to Prague and footing the bill for their own treatment.
The tests were completed this week at the company’s first cancer center in Newport, South Wales, in preparation for the Proteus ONE system — the first high energy proton beam therapy solution to be delivered in the UK - becoming fully operational.
The Rutherford Cancer Center has opened recently to accept patient referrals for conventional cancer treatments and it is anticipated that patients will be treated with proton beam therapy early in 2018.
Mike Moran, chief executive officer of Proton Partners International, said: “This is an important milestone in the development of proton beam therapy in the UK. We’re two months ahead of schedule and for the first time in this country we are beginning to see the reality of high energy proton beam therapy taking shape.
“We look forward to completing the test programming in preparation of treating patients in our first cancer center.
Rare cancer types you've probably never heard of from foot cancer to salivary gland cancer.
The availability of proton beam therapy treatment in the UK will have a significant impact on cancer treatment.
“We’re delighted that the most important day of all, when we are able to treat patients with high energy proton beam therapy, is coming into view.”
Professor Karol Sikora, chief medical officer of Proton Partners International, said: “The availability of proton beam therapy treatment in the UK will have a significant impact on cancer treatment.
“We believe around 10 per cent of all cancer patients could benefit from a very precise form of treatment.
“Furthermore, it will mean that patients who need this type of treatment will not have to travel abroad in future to receive it."